May 2020 – Present · 6 yrs · Margate, England, United Kingdom

• Spencer Private Hospitals is a wholly owned subsidiary of East Kent Hospitals University NHS FT, providing privately and NHS funded treatment on NHS sites at Margate, Ashford and Canterbury.

Jan 2019 – Present · 7 yrs 4 mos · United Kingdom

• DPP https://digitalpathologypartners.com/ provides a high quality, lower cost innovative approach to additional histology reporting
• We create long-term relationships between Trusts and a small number of experienced histopathologists
• These pathologists become flexible part-time remote members of your team
• They report glass slides or digital images directly into your LIMS system

Jan 2018 – Jan 2024 · 6 yrs

• Global health Partnerships supports the development on universal health coverage in LMICs through local presence and making grants such that UK based clinicians can transfer skills to health workers within LMICS.

Sep 2015 – Present · 10 yrs 8 mos · Salisbury, United Kingdom

• Latchmore Associates has a team of very experienced healthcare CEO's, commercial, finance, clinical and business development leaders who also have consulting experience.
• We match resources to fill capacity and capability gaps for NHS and private sector clients. We have particular expertise in the following areas:
• Providing strategic and BD support to companies seeking to enter the UK/ NHS market
• Supporting NHS organisations to grow Private patient profitability, and develop other commercial growth strategies and opportunities
• Supporting NHS organisations to create pathology or radiology partnerships (intra NHS or with private partners)
• Supporting NHS organisations to create and develop commercial activities and partnerships
• Recent projects include:
• Supporting overseas private providers on UK market entry (diagnostics and private patients)
• Supporting overseas digital health companies to gain UK market entry
• Advising 4 STP areas and two overseas groups of public hospitals on pathology integration options
• Advising 12 NHS Trusts on private patient strategy. In three cases, procurement of a private operator.
• Supporting two Trusts to assess private operator interest in managing IVF units
• Advising an NHS Trust on the acquisition and integration of a private hospital
• Developing commercial strategies for three specialist trusts, and overseas tertiary hospital
• Advising Private equity funds on potential healthcare investments
• Writing LaingBuisson reports on: UK IVF market; UK diagnostics market

Mar 2012 – Aug 2015 · 3 yrs 5 mos · UK

• synlab is a leading European pathology services provider with over 6,000 staff across 300 sites in 24 countries, providing over 300 million tests pa, for both hospital, GP and self pay clients across a comprehensive range of pathology specialties. Through their leadership position in the low tariff German market, synlab have developed expertise in delivering high quality customer centred pathology services at low cost. synlab entered the UK diagnostic pathology market in 2012 to collaborating with the NHS and private providers to help them to achieve improved quality at reduced costs. In June 2014, after a 2 year competitive dialogue, we started our first contract - a 10 year joint venture with The Christie NHS FT, to provide routine and specialist oncology pathology services to Christie and other customers. Left when BC Partners sold to Cinven and business merged with Labco.

Jun 2010 – Mar 2018 · 7 yrs 9 mos · London, United Kingdom

• Trustee of a charity which sold 4 care homes, and developed services to support informal carers of people living with dementia.

Oct 2009 – Mar 2012 · 2 yrs 5 mos

• Leading the development of a range of commercial activities for Guy's, including:
• development of private patient activities including a major 25 year deal with HCA to rent 60,000 sq ft PPU at a significant multiple of market value
• commercial support to take-over of £90m PCT community services
• creation of partnership with Linde for step down respiratory services, whereby Linde invested capital to create a new unit at Redhill, supported by GSTT clinicians
• outsourcing dispensing and community pharmacy to Sainsbury
• development of dialysis partnership with Diaverum
• appointment of Amsurg as PB for low complexity gastro services partnership
• successful renewal of highly profitable £35m pa contract to provide health services to British Armed Forces in Germany in partnership with SSAFA
• commercialisation of research, IPR, spin-outs
• commercialisation of support services
• overseas healthcare consultancy and healthcare management contracts (including partnering with other organisations)
• partnering with organisations seeking to sell new services within the NHS
• Trust director on the board of GSTS pathology JV. Led difficult refinancing negotiations with other partners.
• (For the avoidance of doubt, this role was completely separate from Essentia)

Sep 2006 – Mar 2010 · 3 yrs 6 mos

• Oversaw the development of one of the most successful ISTC contracts, delivering excellent clinical outcomes and patient satisfaction (98% NPS), at costs c15-20% below NHS tariff, generating >c£9m EBT on c£30m revenue.
• Led new business wins including: 12 year private neuro patient contract with UCLH; contract to deliver clinical services at Braintree community hospital; JV with leading private hospital group to deliver elective orthopaedics for NHS patients.
• Secured role as operating partner for new private hospital in Republic of Ireland
• Continued as NED for 6 months after leaving CEO role to ensure smooth transition

May 2005 – Sep 2006 · 1 yr 4 mos

• Led business development team selling commissioning support, informatics and long-term commissioning support to PCTs. led review of acquisition targets. Worked on PCT turnaround in collaboration with PWC.

Nov 2002 – May 2005 · 2 yrs 6 mos

• Led the MA's financial turnaround work with failing NHS organisations, including: Bristol, Surrey & Sussex.

Mar 2001 – Nov 2002 · 1 yr 8 mos · Oswestry

• NED helping founders develop business to profitability, organically and through acquisition of Cigna's dental plan business, in preparation for exit

Jan 1998 – Jan 2001 · 3 yrs

• Led turnaround of business from £2.2m operating losses to £1.1m operating profit, through refocused strategy. Led trade sale of main part of business to competitor.

Nov 1993 – Aug 1997 · 3 yrs 9 mos

• Led turnaround of business from £800K losses to £600K profits, on doubled turnover. Disposed of non-core technology/ assets. Acquired more core (social alarm) activity from local government/ housing associations. Initiated and completed joint venture with Age Concern. Left when MBO was outbid by trade bidder.

Jan 1989 – Jan 1993 · 4 yrs

• Range of acquisition review, business strategy and performance improvement projects for clients including WH Smith; ICI Paints; NAAFI.

Jan 1988 – Jan 1992 · 4 yrs

• Co-founded business with UK master license for specialist commercial glazing system company. Raised £135K venture capital. Sold business.

Jan 1984 – Jan 1988 · 4 yrs

• Range of acquisition review, strategy and performance improvement projects for clients including BET; Guinness; Dun & Bradstreet.